Natural bioactive compounds form herbal medicine in Alzheimer’s disease: from the perspective of GSK-3β
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline and memory loss. Glycogen synthase kinase 3β (GSK-3β) plays a pivotal role in AD pathogenesis, particularly in tau protein hyperphosphorylation. Natural bioactive compounds have a wide range of so...
Saved in:
Main Authors: | Mei Wang, Wendi Huang, Juan Huang, Yong Luo, Nanqu Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1497861/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Protective Effect of Mangiferin on Formaldehyde-Induced HT22 Cell Damage and Cognitive Impairment
by: Fan Chen, et al.
Published: (2023-05-01) -
Cerebrospinal fluid β2-microglobulin promotes the tau pathology through microglia–astrocyte communication in Alzheimer's disease
by: Zehu Sheng, et al.
Published: (2025-01-01) -
C/EBPβ in Alzheimer’s disease: An integrative regulator of pathological mechanisms
by: Xiaoting Luo, et al.
Published: (2025-02-01) -
Plasma S100β is a predictor for pathology and cognitive decline in Alzheimer’s disease
by: Geetika Nehra, et al.
Published: (2025-01-01) -
Developing non-invasive molecular markers for early risk assessment of Alzheimer's disease
by: Tapas K. Sur, et al.
Published: (2025-06-01)